The drug use at the basic level of 4 provinces has been fully liberalized, and the 130 billion market has exploded!

Source: Cypress blue 2018-02-05 medical network February 3 news 4 provincial basic medical institutions, medication completely open! Domestic and foreign pharmaceutical companies are fighting for 130 billion markets ▍ from February, Tianjin opened all the drug catalogs of medical institutions On the last day of January 2018, Tianjin Medical purchasing center issued Tianjin notice on adjusting the scope of drug online purchasing of primary medical institutions Notice to all units that from February 1, the scope of online drug procurement of primary medical institutions in Tianjin will be fully connected with the use of drugs in secondary and tertiary hospitals That is to say, all public medical institutions in Tianjin have unified drug use catalogues, and grass-roots drug use is no longer limited Data published by Tianjin municipal government in 2016: in 2014, there were 4990 medical and health institutions in Tianjin, including 373 hospitals (39 tertiary hospitals, 54 secondary hospitals, 280 primary hospitals, 211 private hospitals), 4419 primary medical institutions and 145 professional public health institutions Since then, 4419 primary medical institutions have completely liberalized the use of drugs ▍ 4 provinces (cities), in fact, not only Tianjin, but also Beijing, Guangdong and Liaoning lifted the restrictions on drug use at the grassroots level in 2017 On April 8, 2017, Beijing Sunshine procurement expanded the directory of primary medical institutions, integrating the original primary medical institutions with the drug procurement platform of the second and third level hospitals, so as to achieve the complete consistency of drug use On June 30, the health and Family Planning Commission of Guangdong Province issued the notice on further clarifying the relevant requirements of the basic drug system of our province Since July 1, 2017, there will be no specific requirements on the quantity and amount proportion of national basic drugs used by medical institutions at all levels On August 1, Liaoning Province issued the implementation opinions on further reform and improvement of drug production, circulation and use policies, requiring medical institutions at all levels to implement a unified procurement platform and directory In addition, other provinces in the country are also gradually increasing the proportion of non-basic drugs used in primary medical institutions For example, Anhui, Shandong, Sichuan, Zhejiang and so on, the specific documents will not be described in detail Generally speaking, it is an inevitable trend to get through grassroots medicine and the top three drugs It is just a matter of time and night based on the differences in financial resources of each province ▍ it's very easy to make such a judgment on the general trend that all levels of medical institutions use drugs in a unified way In the guidance on promoting the construction and development of medical consortia issued by the State Office in April 2017, it allows "medical consortia to become a community of service, responsibility, interest and management", and gives the task of "all secondary public hospitals and grass-roots medical institutions run by the government to participate in medical consortia" in 2020 After that, the trusteeship of large hospitals to small and medium-sized hospitals has been promoted rapidly In this context, the unification of drug use catalogues at all levels of hospitals is an inevitable result ▍ with the rapid expansion of the market of 130 billion yuan, pharmaceutical enterprises have to contend for a place As mentioned above, the unified documents of drug use of medical institutions at all levels in many provinces are proving this judgment step by step What's good for pharmaceutical companies is the huge market According to the data from CFDA Nanfang Institute, in 2016, the market share of primary public medical institutions increased from 6.6% in 2011 to 9.1%, with a total amount of more than 130 billion yuan And since 2010, it has maintained an average annual growth rate of 23.7% This is a policy dividend Many foreign pharmaceutical companies, such as Pfizer and Sanofi, have been emphasizing channel sinking for several years, and have seen this potential market for a long time At present, the operation of grade hospitals is becoming more and more difficult, and the market of more than 100 billion is emerging gradually, which is sure to be the only place for pharmaceutical enterprises.